Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

Journal of Clinical Investigation

Volumn 99, Issue 12, 1997, Pages 3025-3033

  Rossol, Siegbert ^a,c   Marinos, George ^a   Carucci, Patrizia ^a   Singer, Manfred V ^c   Williams, Roger ^a,b   Naoumov, Nikolai V ^a,b,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chronic hepatitis B; Hepatitis B virus; Interleukin 12; T helper cytokines; Th1 Th2 cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS HEPATITIS;

EID: 0030959049     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119498     Document Type: Article

References (30)

1. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
2. Marinos, G., F. Torre, S. Chokshi, M. Hussain, B.E. Clarke, D.J. Rowlands, A.L. Eddleston, N.V. Naoumov, and R. Williams. 1995. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepalology. 22:1040-1049.
3. Tsai, S.L., P.J. Chen, M.Y. Lai, P.M. Yang, J.L. Sung, J.H. Huang, L.H. Hwang, T.H. Chang, and D.S. Chen. 1992. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J. Clin. Invest. 89:87-96.
4. Löhr, H.F., W. Weber, J. Schlaak, B. Goergen, K.H. Meyer zum Büschenfelde, and G. Gerken. 1995. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology. 22:61-68.
5. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
6. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
7. Maruyama, T., S. Iino, K. Koike, K. Yasuda, and D.R. Milich. 1993. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology. 105:1141-1151.
8. Maruyama, T., A. McLachlan, S. Iino, K. Koike, K. Kurokawa, and D.R. Milich. 1993. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 91:2586-2595.
9. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
10. Gately, M.K., A.C. Wolitzky, P.M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolylic lymphocyte responses by interleukin-12. Cell. Immunol. 143:127-142.
11. Gazzineili, R.T., M. Wysocka, S. Hayashi, E.Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
12. Zhang, M., M.K. Gately, E. Wang, J. Gong, S.F. Wolf, S. Lu, R.L. Modlin, and P.P. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733-1739.
13. Clerici, M., D.R. Lucey, J.A. Berzofsky, L.A. Pinto, T.A. Wynn, S.P. Blatt, M.J. Dolan, C.W. Hendrix, S.F. Wolf, and G.M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (Wash. DC). 262:1721-1724.
14. Desmet, V.J., M. Gerber, J.H., Hoofnagle, M. Manns, and P.J. Scheuer. 1994. Classification of chronic hepatitis: diagnosis, grading and staging. Hepalology. 19:1513-1520.
15. Rossol, S., R. Voth, H.P. Laubenstein, W.E.G. Müller, H.C. Schröder. K.H. Meyerz zum Büschenfelde, and G. Hess. 1989. Interferon production in patients infected with HIV-1. J. Infect. Dis. 159:815-821.
16. Chisari, F.V. 1995. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology. 22:1316-1325.
17. Ando, K., L.G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R.D. Schreiber, H.J. Schlicht, S.N. Huang, and F.V. Chisari. 1994. Class 1-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
18. Gilles, P.N., G. Fey, and F.V. Chisari. 1992. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955-3960.
19. Guilhot, S., L.G. Guidotti, and F.V. Chisari. 1993. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J. Virol. 67:7444-7449.
20. Guidotti, L.G., S. Guilhot, and F.V. Chisari. 1994. Interleukin-2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumour necrosis factor dependent and independent pathways. J. Virol. 68:1265-1270.
21. Guidotti, L.G., K. Ando, M.V. Hobbs, T. Ishikawa, L. Runkel, R.D. Schreiber, and F.V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:3764-3768.
22. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
23. Jilbert, A.R., T.f. Wu, J.M. England, P.M. Hall, N.Z. Carp, A.P. O'Connell, and W.S. Mason. 1992. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1377-1388.
24. Kajino, K., A.R. Jilbert, J. Saputelli, C.E. Aldrich, J. Cullen, and W.S. Mason. 1994. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepalocyte. J. Virol. 68:5792-5803.
25. Jung, M.-C., U. Spengler, W. Schraut, R. Hoffmann, R. Zachoval, J. Eisenberg, D. Eichenlaub, G. Riethmüller, G. Paumgartner, H.W.L. Ziegler-Heitbrock, et al. 1991. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. 13:310-317.
26. Marinos, G., H.M. Smith, N.V. Naoumov, and R. Williams. 1994. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology. 19:303-311.
27. Maruyama, T., F. Schodel, S. Iino, K. Koike, K. Yasuda, D. Peterson, and D.R. Milich. 1994. Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology. 106:1006-1015.
28. Milich, D.R., S.F. Wolf, J.L. Hughes, and J.E. Jones. 1995. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc. Natl. Acad. Sci. USA. 92:6847-6851.
29. Wenner, C.A., M.L. Guler, S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1996. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442-1447.
30. Bertagnolli, M.M., B.Y. Lin, D. Young, and S.H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778-3783.